JP2002520288A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002520288A5 JP2002520288A5 JP2000558827A JP2000558827A JP2002520288A5 JP 2002520288 A5 JP2002520288 A5 JP 2002520288A5 JP 2000558827 A JP2000558827 A JP 2000558827A JP 2000558827 A JP2000558827 A JP 2000558827A JP 2002520288 A5 JP2002520288 A5 JP 2002520288A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- substituted
- group
- alkyl
- heteroalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 description 44
- 125000000217 alkyl group Chemical group 0.000 description 22
- 125000006716 (C1-C6) heteroalkyl group Chemical group 0.000 description 16
- 125000003118 aryl group Chemical group 0.000 description 12
- 229910052739 hydrogen Inorganic materials 0.000 description 12
- 239000001257 hydrogen Substances 0.000 description 12
- 150000002431 hydrogen Chemical class 0.000 description 11
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 8
- 125000003710 aryl alkyl group Chemical group 0.000 description 8
- -1 nitro, carboxyl Chemical group 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 229910052717 sulfur Inorganic materials 0.000 description 8
- 125000000547 substituted alkyl group Chemical group 0.000 description 7
- 125000003107 substituted aryl group Chemical group 0.000 description 7
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 7
- 125000002252 acyl group Chemical group 0.000 description 6
- 125000003545 alkoxy group Chemical group 0.000 description 5
- 125000004181 carboxyalkyl group Chemical group 0.000 description 5
- 125000004405 heteroalkoxy group Chemical group 0.000 description 5
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- 125000006575 electron-withdrawing group Chemical group 0.000 description 3
- 239000003574 free electron Substances 0.000 description 3
- 125000000623 heterocyclic group Chemical class 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 229940045799 anthracyclines and related substance Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000004404 heteroalkyl group Chemical group 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 125000005358 mercaptoalkyl group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/114,860 US6214330B1 (en) | 1998-07-13 | 1998-07-13 | Coumarin and related aromatic-based polymeric prodrugs |
| US09/114,860 | 1998-07-13 | ||
| PCT/US1999/015652 WO2000002568A1 (en) | 1998-07-13 | 1999-07-12 | Coumarin and related aromatic-based polymeric prodrugs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002520288A JP2002520288A (ja) | 2002-07-09 |
| JP2002520288A5 true JP2002520288A5 (enExample) | 2006-08-10 |
| JP4999226B2 JP4999226B2 (ja) | 2012-08-15 |
Family
ID=22357836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000558827A Expired - Fee Related JP4999226B2 (ja) | 1998-07-13 | 1999-07-12 | クマリン及び関連芳香族系ポリマープロドラッグ |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6214330B1 (enExample) |
| EP (1) | EP1102592B1 (enExample) |
| JP (1) | JP4999226B2 (enExample) |
| AT (1) | ATE266424T1 (enExample) |
| AU (1) | AU4983999A (enExample) |
| CA (1) | CA2336663C (enExample) |
| DE (1) | DE69917281T2 (enExample) |
| DK (1) | DK1102592T3 (enExample) |
| WO (1) | WO2000002568A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004264958B2 (en) | 2003-08-13 | 2010-04-15 | Biocon, Ltd | Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
| US7534902B2 (en) * | 2003-11-14 | 2009-05-19 | Wisconsin Alumni Research Foundation | Fluorescence assays with improved sensitivity |
| US20090214472A1 (en) * | 2004-03-01 | 2009-08-27 | Enzon Pharmaceuticals Inc. | Interferon-beta polymer conjugates |
| JP2007533750A (ja) * | 2004-04-21 | 2007-11-22 | アルザ コーポレイション | 緩和なチオール分解条件下で遊離可能なポリマー結合体 |
| MXPA06012144A (es) * | 2004-04-21 | 2007-01-31 | Alza Corp | Conjugado polimerico liberable bajo condiciones tioliticas suaves. |
| US8367065B2 (en) * | 2006-09-15 | 2013-02-05 | Enzon Pharmaceuticals, Inc. | Targeted polymeric prodrugs containing multifunctional linkers |
| JP2010503708A (ja) * | 2006-09-15 | 2010-02-04 | エンゾン ファーマスーティカルズ インコーポレイテッド | 多官能性リンカーを含む標的化ポリマープロドラッグ |
| CA2693645A1 (en) * | 2007-07-11 | 2009-01-15 | Enzon Pharmaceuticals, Inc. | Polymeric drug delivery systems containing an aromatic allylic acid |
| BRPI0818004B8 (pt) | 2007-10-16 | 2021-05-25 | Biocon Ltd | composição farmacêutica sólida administrável por via oral e o processo da mesma. |
| US20100227327A1 (en) * | 2008-08-08 | 2010-09-09 | Xiaoliang Sunney Xie | Methods and compositions for continuous single-molecule nucleic acid sequencing by synthesis with fluorogenic nucleotides |
| US20100036110A1 (en) * | 2008-08-08 | 2010-02-11 | Xiaoliang Sunney Xie | Methods and compositions for continuous single-molecule nucleic acid sequencing by synthesis with fluorogenic nucleotides |
| JP6747971B2 (ja) | 2013-10-15 | 2020-08-26 | シアトル ジェネティックス， インコーポレイテッド | 改善されたリガンド−薬物コンジュゲート薬物動態のためのｐｅｇ化薬物−リンカー |
| US11229708B2 (en) | 2015-12-04 | 2022-01-25 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
| US11793880B2 (en) | 2015-12-04 | 2023-10-24 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
| EP3433278A4 (en) | 2016-03-25 | 2019-11-06 | Seattle Genetics, Inc. | METHOD FOR THE PRODUCTION OF PEGYLATED ACTIVE LINKERS AND INTERMEDIATE PRODUCTS THEREOF |
| CN110430901B (zh) | 2017-03-24 | 2024-08-16 | 西雅图基因公司 | 制备葡糖苷酸药物-接头及其中间体的方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4399282A (en) * | 1979-07-10 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives |
| US4943579A (en) * | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
| FR2676058B1 (fr) | 1991-04-30 | 1994-02-25 | Hoechst Lab | Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers. |
| EP0727992A4 (en) * | 1993-10-20 | 2001-01-31 | Enzon Inc | SUBSTITUTED TAXOID SUBSTANCES IN 2 'AND / OR 7' POSITION |
| US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| ES2227536T3 (es) | 1995-06-27 | 2005-04-01 | Pharmachemie B.V. | Nuevos profarmacos de antraciclina, procedimiento de preparacion asi como su uso en quimioterapia selectiva. |
| JPH1087815A (ja) * | 1996-08-22 | 1998-04-07 | Enzon Inc | ポリアルキレンオキシドカルボン酸の改良製造方法 |
| EP0961619A4 (en) | 1996-09-27 | 2001-09-26 | Bristol Myers Squibb Co | HYDROLYSABLE DRUGS FOR THE RELEASE OF ANTI-CANCER DRUGS IN METASTATIC CELLS |
-
1998
- 1998-07-13 US US09/114,860 patent/US6214330B1/en not_active Expired - Lifetime
-
1999
- 1999-07-12 DK DK99933882T patent/DK1102592T3/da active
- 1999-07-12 DE DE69917281T patent/DE69917281T2/de not_active Expired - Lifetime
- 1999-07-12 AT AT99933882T patent/ATE266424T1/de not_active IP Right Cessation
- 1999-07-12 JP JP2000558827A patent/JP4999226B2/ja not_active Expired - Fee Related
- 1999-07-12 CA CA002336663A patent/CA2336663C/en not_active Expired - Fee Related
- 1999-07-12 EP EP99933882A patent/EP1102592B1/en not_active Expired - Lifetime
- 1999-07-12 AU AU49839/99A patent/AU4983999A/en not_active Abandoned
- 1999-07-12 WO PCT/US1999/015652 patent/WO2000002568A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002508400A5 (enExample) | ||
| JP2002520288A5 (enExample) | ||
| AU2010212335B2 (en) | Polymeric prodrug with a self-immolative linker | |
| CA2830052C (en) | Injectable dendrimer hydrogel nanoparticles | |
| JP4860813B2 (ja) | 末端分枝ポリマーリンカーおよびそれを含有するポリマーコンジュゲート | |
| JP5312050B2 (ja) | 分割型の分解性重合体とそれから生成される複合体 | |
| CN102985462B (zh) | 支链异聚乙二醇和中间体 | |
| CA2462085A1 (en) | Cytotoxic agents | |
| CA2394716A1 (en) | Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) | |
| US20090016985A1 (en) | Polymeric drug delivery system containing a multi-substituted aromatic moiety | |
| US20090203706A1 (en) | Lysine-based polymeric linkers | |
| CA2312975A1 (en) | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents | |
| US20020099164A1 (en) | Novel amphiphilic polymeric materials | |
| CA2309954A1 (en) | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents | |
| US20040105839A1 (en) | Biologically active non-antigenic copolymer and conjugates thereof and methods for producing the same | |
| JP2005524657A5 (enExample) | ||
| EP1699491A2 (en) | Branched polyethylene glycol for linking polymer residues to antibodies | |
| CA2448319A1 (en) | Cytotoxins, prodrugs, linkers and stabilizers useful therefor | |
| CA2695532A1 (en) | Polymeric linkers containing pyridyl disulfide moieties | |
| JP2004532289A5 (enExample) | ||
| CN104024306A (zh) | 聚噁唑啉聚合物及其制备方法、这些聚合物的结合物及其医疗用途 | |
| JP2005504006A5 (enExample) | ||
| JP2014501765A5 (enExample) | ||
| JP2014503548A5 (enExample) | ||
| EP0992509A3 (en) | Novel macrolide derivatives |